




































Telomeres consist of long (TTAGGG)n nucleotide 
repeats and an ordered protein complex at the ends of 
chromosomes that are essential to maintaining 
chromosomal integrity [1]. Telomere length (TL) 
shortens with each cell division and thus is an important 
marker of aging. It is also associated with the risk of 
several degenerative and age related diseases, including 
cancer [2,3]. Individuals with dyskeratosis congenita 
(DC), a cancer susceptibility and inherited bone marrow 
failure syndrome (IBMFS), have mutations in genes 
important in telomere biology, including DKC1, TERC, 
TERT, TINF2, NHP2 and NOP10 [4].  They also have 
very short telomeres for age compared with unaffected 
family members or age-matched controls [5]. Typically, 
DC is clinically defined by the triad of lacy, reticular 
skin pigmentation, nail dystrophy, and oral leukoplakia.  
Patients  are  at very high  risk of  bone  marrow  failure,  
 
 


































cancer, pulmonary fibrosis, and other medical 
complications [4,6]. The presence of very short 
telomeres in leukocyte subsets as measured by auto-
mated multicolor fluorescence in situ hybridization 
combined with flow-cytometry (flow-FISH) [7] , is a 
useful tool for differentiating patients with DC from 
healthy individuals [8,9].  
 
TL abnormalities have been reported in a few patients 
with other IBMFS, including Fanconi anemia (FA) 
[10,11], Shwachman Diamond syndrome (SDS) [12], 
and, to a lesser extent, in Diamond Blackfan anemia 
(DBA) [13], but the degree of telomere shortening               
is usually not as profound as in DC. When compared 
with DC, the short telomeres in patients with non-DC 
IBMFS are mainly observed in granulocytes [8], 
suggesting the presence of rapid granulocyte stem/ 
progenitor cell turnover in response to bone marrow 
stress.    
Telomere length in blood, buccal cells, and fibroblasts from patients
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correlations between TL measured in different tissues 
from the same individual are limited. Some studies, 
mostly in the elderly, suggest a possible variability         
in TL across tissues [14-17]. Studies of telomere 
length in cancer and other diseases have only 
evaluated either the abnormal tissue [18-20], 
peripheral blood [21-23], or buccal cells [24,25]. In 
one study, the average TL in five different tissue types, 
cerebral cortex, myocardium, liver, renal cortex and 













































Studies of TL in DC patients also showed short 
telomeres in cultured skin fibroblasts [27] and 
keratinocytes [28]. 
 
In order to better understand intra-individual TL 
variation in IBMFS, we compared TL, measured by Q-
PCR, in DNA extracted from blood, buccal cells, and 
cultured fibroblasts within and between the four major 
IBMFS disorders, DC, FA, SDS, and DBA. We also 
assessed TL intra-individual correlations between 
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Abbreviations:  IBMFS,  inherited  bone  marrow  failure  syndromes;  DC,  dyskeratosis  congenita;  FA,  Fanconi  Anemia;  DBA, 
Diamond Blackfan Anemia; SDS, Shwachman Diamond Syndrome; N, number; Kb, kilobases 
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Table 1 summarizes the characteristics of the study 
participants. The ages of the patients ranged from 8 to 
43 years (median=21), most were males (71.4%), and 
about one-fourth had severe aplastic anemia.  As 
expected, telomeres were significantly shorter in 
patients with DC than in patients with other IBMFS in 
blood (median T/S, or relative TL=0.61 vs. 1.13, 
p=0.001), buccal cells (0.80 vs. 1.25, p=0.009), and 
fibroblasts (0.84 vs. 1.56, p=0.001) (Figure 1). In all 
IBMFS patients combined, median TL was longer in 
fibroblasts and buccal cells when compared with blood 
(1.42 and 1.16 vs. 1.05, p=0.001, 0.006, respectively) 
(Figure1). The same pattern was observed across each 
specific IBMFS (Table 2)  
 
When evaluating the intra-individual correlations be-





































trios in all IBMFS patients, we observed significant 
correlations between blood and fibroblasts (r=0.66, 
p=0.002), blood and buccal cells (r=0.74, p<0.0001), 
and fibroblasts and buccal cells (r=0.65, p=0.004) 
measurements. Disease-specific analyses showed that 
this correlation was primarily derived from the           
strong correlation between TL in blood and buccal 
(r=0.90, p=0.04), buccal and fibroblast (r=0.90, p=0.04) 
in patients with DC, and TL in blood and fibroblast 
(r=1.0, p<0.0001) in patients with SDS. Likewise,           
we observed a positive, however not statistically 
significant, correlation between TL in buccal cells         
and blood in patients with FA (r=0.60, p=0.28) and 
DBA (r=0.70, p=0.19). A positive non-significant 
correlation was also observed between fibroblast and 
buccal TL in patients with DBA (r=0.70, p=0.19). 
Surprisingly, a strong negative correlation was present 
between fibroblast and buccal TL (r=-1.0, p<0.0001)     
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Figure 1. Comparison of Q‐PCR blood, fibroblast and buccal cell DNA telomere length (TL) in DC patients,
and patients with other IBMFS combined. Q‐PCR TL (on the Y axis) is measured as a ratio of telomere copy





























































Tissue type  Number  Median TL Range p-value* 
All patients with IBMFS
Blood  21  1.05 0.40-1.86 Reference 
Buccal cells  19  1.16 0.51-6.44 0.006 
Fibroblasts  20  1.42  0.47-2.20 0.001 
Dyskeratosis Congenita 
Blood  6  0.61 0.40-0.99 Reference 
Buccal cells  5  0.80 0.51-1.16 0.04 
Fibroblasts  6  0.84 0.47-1.16 0.17 
Fanconi Anemia 
Blood  6  1.13 0.79-1.35 Reference 
Buccal cells  5  1.22 0.96-1.46 0.70 
Fibroblasts  5  1.73 1.39-2.20 0.04 
Diamond-Blackfan Anemia
Blood  5  1.13 0.99-1.86 Reference 
Buccal cells  5  1.52 1.03-2.23 0.08 
Fibroblasts  5  1.60 1.15-1.69 0.14 
Shwachman-Diamond Syndrome
Blood  4  1.18 0.99-1.54 Reference 
Buccal cells  3  1.39 1.04-6.44 0.11 










Proper telomere length and structure are critical for 
chromosomal stability.  Telomeres shorten with each 
cell division and are also susceptible to oxidative stress.  
TL is an important marker for aging, and appears to be 
associated with risk of several diseases, including 
cancer. Telomere biology disorders encompass a broad 
clinical spectrum, ranging from dyskeratosis congenita 
with its diagnostic triad and young age of onset, to 
isolated aplastic anemia or pulmonary fibrosis 
diagnosed later in life [29]. Telomeres have been 
reported to be shorter than normal in some patients with 
FA, SDS, and DBA, but in these cases they are not as 









































understand the variability in telomere length within and 
between different tissues derived from patients with 
these IBMFS. 
 
In all IBMFS patients combined, TL in DNA samples 
extracted from blood was significantly shorter than that 
extracted from fibroblasts or buccal cells; a pattern that 
was observed across disorders, but did not reach 
statistical significance in some of them. More than half 
(57%) of our patients had moderate to severe aplastic 
anemia and the remainder are at high risk of its 
development.  It is possible that the shorter telomeres in 
patients’ blood cells could be a result of higher telo-
mere attrition due to the relatively rapid turnover of 
hematopoietic  cells  in  response to bone marrow stress.   









All patients with IBMFS
Blood 21 1.00 20 0.66** 19 0.74** 
Fibroblast  20 0.67** 20 1.00 18 0.65** 
Dyskeratosis Congenita 
Blood 6  1.00 6 0.45 5 0.90* 
Fibroblast  6  0.43 6 1.00 5 0.90* 
Fanconi anemia 
Blood 6  1.00 5 -0.10 5 0.60 
Fibroblast  5  -0.10 5 1.00 4 -1.00** 
Diamond-Blackfan Anemia
Blood 5  1.00 5 0.30 5 0.70 
Fibroblast  5  0.30 5 1.00 5 0.70 
Shwachman-Diamond Syndrome 
Blood 4  1.00 4 1.00** 4 0.50 
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telomere biology. Our finding of longer telomeres in 
fibroblasts than in blood cells is in agreement with 
another report of TL in healthy centenarians and 
controls of different ages [16].  In support of this 
observation, a higher annual rate of telomere attrition 
has been reported in leukocytes (approximately 
30bp/year) [16;30;31] than in fibroblasts (15bp/year) 
[32]. When comparing blood and buccal telomere 
length, our finding was discordant with the reported 
longer telomeres in leukocytes compared with buccal 
cells in patients with Alzheimer disease and their age-
matched controls [17]; this difference could be due to 
differences in disease biology, different DNA extraction 
methods and/or limitations in sample size. 
 
Although the absolute TL values varied between blood, 
buccal cells, and fibroblast DNA, we observed strong 
intra-individual correlations between the three tissues; 
buccal cells showed consistent correlation across 
IBMFS; however, this correlation did not reach 
statistical significance when the disorders were 
evaluated individually. This finding is in contrast to the 
observed lack of correlation between blood and buccal 
TL in healthy individuals and patients with Alzheimer’s 
disease reported by another study [17]. Surprisingly, we 
observed an inverse correlation between buccal cell and 
fibroblast TL in patients with FA. This could 
theoretically be related to the high oral cancer 
susceptibility in FA patients. Of the 5 patients with FA 
included in this study, one had oral cancer 3 years prior 
to as well as 2 years after sample collection; a second 
patient with FA had oral cancer 5 years after sample 
collection. Larger sample sizes are required to better 
understand these findings. Our observed strong 
correlation between blood and fibroblast TL in patients 
with SDS is an interesting finding that needs further 
evaluation. 
 
TL correlations in different tissues have been observed 
in several other studies. Specifically, between 
fibroblasts and leukocytes (r
2=0.80, p=0.0006)[15],   
bone marrow and skin (r
2 = 0.77), vocal fold and blood 
(r
2 = 0.84), skin and vocal folds (r
2=0.62)[33], 
epidermal and lingual epithelium (r=0.84, p<0.0001) 
[34], and each pair of the following tissues: cerebral 
cortex, myocardium, liver, and renal cortex [26]. In our 
study, we observed a strong correlation profile between 
evaluated DNA samples in patients with DC, where 
heritable telomere dysfunction is present, particularly 
between blood and buccal cells (r=0.90) and buccal 
cells and fibroblasts (r=0.90). This suggests that short 
telomeres in DC are not limited to blood or fibroblasts, 
observations that have been previously reported [27], 
but are also present in buccal cells. This finding also 
suggests that the heritability of telomere length in DC is 
tissue independent.  
 
In conclusion, overall Q-PCR TL in patients with 
IBMFS was correlated between blood, buccal cells and 
fibroblasts, but there was some variability within 
different IBMFS. This small pilot study suggests that 
blood or tissue Q-PCR TL could theoretically be useful 
as a first screen for individuals with a suspected 
telomere biology disorder. However, much larger 
studies are needed to evaluate the reliability and validity 
of this test in comparison to the standard diagnostic 




Ethical statement. This investigation was conducted in 
accordance with the ethical standards and according to 
the Declaration of Helsinki and the national and 
international guidelines and has been approved by the 
National Cancer Institute’s (NCI) institutional review 
board. 
 
Study participants. The study included 21 patients with 
IBMFS; 5 Diamond Blackfan anemia (DBA), 6 
Dyskeratosis Congenita (DC), 6 Fanconi anemia (FA), 
and 4 Shwachman-Diamond syndrome (SDS) who were 
enrolled in the NCI study entitled “Etiologic 
Investigation of Cancer Susceptibility in Inherited Bone 
Marrow Failure Syndromes” and provided blood, 
buccal cells, and fibroblast samples. Study details are 
available elsewhere [35]. Briefly, evaluation of patients 
described in this cohort includes systematic review of 
medical records, careful physical examination, complete 
blood counts, bone marrow studies, skin biopsy, buccal 
cell collection, and other appropriate diagnostic tests. 
 
DNA extraction and telomere length measurements. 
Genomic DNA from blood cells was extracted from 
either whole blood (4 samples; 3 DBA and 1 DC) or the 
white blood cell pellet remaining after density gradient 
separation (17 samples, primarily granulocytes) by 
manual Gentra Puregene procedure (Qiagen Inc., 
Valencia, CA). Skin fibroblasts were cultured from 
punch biopsies and stored at -80˚C.  Buccal cells were 
collected using Scope mouthwash.  DNA was isolated 
from fibroblasts and buccal cells by phenol-chloroform 
extraction.  
 
TL was measured using the Quantitative- Polymerase 
Chain Reaction (Q-PCR) method previously described 
[36].  Briefly, the relative TL was estimated from the 
ratio of the telomere (T) repeat copy number to a single 
gene (human β-globin gene) (S) copy number (T/S 
ratio) for each sample using standard curves.  For 
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in triplicates. The average coefficients of variation (CV) 
between triplets for blood, buccal and fibroblast 
samples were 6.4%, 7.3%, and 7.9%, respectively. 
 
Statistical analysis. We used Wilcoxon signed-rank test 
to compare the median ranks of TL within each disorder 
(buccal, and fibroblast vs. blood), and Mann-Whitney 
test to compare tissue-specific TL between DC and 
other IBMFS. Spearman rank correlation coefficient (R) 
was used to evaluate the intra-individual correlations 
between Q-PCR TL in blood-fibroblast-buccal cell 
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